174 related articles for article (PubMed ID: 10389686)
21. Increased serum pancreatitis associated protein (PAP) concentration after longterm alcohol consumption: further evidence for regular subclinical pancreatic damage after heavy drinking?
Nordback I; Jaakkola M; Iovanna JL; Dagorn JC
Gut; 1995 Jan; 36(1):117-20. PubMed ID: 7890213
[TBL] [Abstract][Full Text] [Related]
22. The pancreatitis-associated protein in hereditary and chronic alcoholic pancreatitis.
Keim V; Hoffmeister A; Teich N; Halm U; Scheurlen M; Tannapfel A; Mössner J
Pancreas; 1999 Oct; 19(3):248-54. PubMed ID: 10505755
[TBL] [Abstract][Full Text] [Related]
23. The pancreatitis-associated protein I promoter allows targeting to the pancreas of a foreign gene, whose expression is up-regulated during pancreatic inflammation.
Dusetti NJ; Vasseur S; Ortiz EM; Romeo H; Dagorn JC; Burrone O; Iovanna JL
J Biol Chem; 1997 Feb; 272(9):5800-4. PubMed ID: 9038194
[TBL] [Abstract][Full Text] [Related]
24. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
[TBL] [Abstract][Full Text] [Related]
25. TNM staging for GIT cancers is correlated with the level of MMPs and TGF-β1.
El-Ashmawy NE; Khedr NF; Mansour MG; Al-Ashmawy GM
Clin Exp Med; 2020 Nov; 20(4):545-555. PubMed ID: 32772210
[TBL] [Abstract][Full Text] [Related]
26. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
Pezzilli R; Billi P; Plate L; Laudadio MA; Sprovieri G
Ital J Gastroenterol; 1995; 27(6):296-9. PubMed ID: 8562994
[TBL] [Abstract][Full Text] [Related]
27. Serum measurements of pancreatitis associated protein in active Crohn's disease with ileal location.
Desjeux A; Barthet M; Barthellemy S; Dagorn JC; Hastier P; Heresbach D; Bernard JP; Grimaud JC
Gastroenterol Clin Biol; 2002 Jan; 26(1):23-8. PubMed ID: 11938036
[TBL] [Abstract][Full Text] [Related]
28. Human pancreatitis-associated protein. Messenger RNA cloning and expression in pancreatic diseases.
Orelle B; Keim V; Masciotra L; Dagorn JC; Iovanna JL
J Clin Invest; 1992 Dec; 90(6):2284-91. PubMed ID: 1469087
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of pancreatitis-associated protein (PAP) in human pancreatic ductal adenocarcinoma.
Xie MJ; Motoo Y; Iovanna JL; Su SB; Ohtsubo K; Matsubara F; Sawabu N
Dig Dis Sci; 2003 Mar; 48(3):459-64. PubMed ID: 12757156
[TBL] [Abstract][Full Text] [Related]
30. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer.
Ventrucci M; Cipolla A; Racchini C; Casadei R; Simoni P; Gullo L
Dig Dis Sci; 2004 Aug; 49(7-8):1149-55. PubMed ID: 15387337
[TBL] [Abstract][Full Text] [Related]
31. The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study.
Yüceyar S; Ertürk S; Dirican A; Cengiz A; Saner H
Int Surg; 1996; 81(2):136-9. PubMed ID: 8912078
[TBL] [Abstract][Full Text] [Related]
32. Messenger RNA sequence and expression of rat pancreatitis-associated protein, a lectin-related protein overexpressed during acute experimental pancreatitis.
Iovanna J; Orelle B; Keim V; Dagorn JC
J Biol Chem; 1991 Dec; 266(36):24664-9. PubMed ID: 1722211
[TBL] [Abstract][Full Text] [Related]
33. Regulation of mouse pancreatitis-associated protein-I gene expression during caerulein-induced acute pancreatitis.
Fu K; Sarras MP; De Lisle RC; Andrews GK
Digestion; 1996; 57(5):333-40. PubMed ID: 8886577
[TBL] [Abstract][Full Text] [Related]
34. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
35. Identification of a second rat pancreatitis-associated protein. Messenger RNA cloning, gene structure, and expression during acute pancreatitis.
Frigerio JM; Dusetti NJ; Keim V; Dagorn JC; Iovanna JL
Biochemistry; 1993 Sep; 32(35):9236-41. PubMed ID: 8369291
[TBL] [Abstract][Full Text] [Related]
36. Conformational changes of pancreatitis-associated protein (PAP) activated by trypsin lead to insoluble protein aggregates.
Schiesser M; Bimmler D; Frick TW; Graf R
Pancreas; 2001 Mar; 22(2):186-92. PubMed ID: 11249074
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of tumor-associated antigen (2H6 antigen) in detecting early stages of gastric cancer.
Harada H; Tsukada Y; Karasawa Y
Clin Chim Acta; 1994 Aug; 228(2):101-12. PubMed ID: 7527311
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
[TBL] [Abstract][Full Text] [Related]
40. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
